Intraocular Infection

Between 2006 and 2015, nearly 125,000 patients in the U.S. have received nearly a million injections of anti-VEGF medicines for the treatment of retinal disease, according to Parikh and colleagues. Nearly two-thirds of the injections have been for wet age-related macular degeneration.